Chemogenomic strategies to expand the bioactive chemical space

Current Medicinal Chemistry

Volumn 16, Issue 33, 2009, Pages 4374-4381

  Jacoby, E ^a   Mozzarelli, A ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

BIOS; Chemogenomics; Co factor; DOS; Privileged structure; Secondary structure mimetics; Target families

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHOLECYSTOKININ; CYCLIN DEPENDENT KINASE 2; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; PROTEIN MDM2; PYRIDOXINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ALPHA HELIX; BINDING AFFINITY; BINDING SITE; DRUG DESIGN; LIGAND BINDING; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN TARGETING; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

BIOMIMETICS; COMBINATORIAL CHEMISTRY TECHNIQUES; GENOMICS; LIGANDS; PROTEIN STRUCTURE, SECONDARY; SMALL MOLECULE LIBRARIES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70450199467     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709789712862     Document Type: Short Survey

References (54)

1. Dobson, C.M. Chemical space and biology. Nature 2004, 432, 824-828
2. Paolini, G.V.; Shapland, R.H.; van Hoorn, W.P.; Mason, J.S.; Hopkins, A.L. Global mapping of pharmacological space. Nat. Biotechnol. 2006, 24, 805-815
3. Overington, J.P.; Al-Lazikani, B.; Hopkins, A.L. How many drug targets are there? Nat. Rev. Drug Discov. 2006, 5, 993-996 (Pubitemid 44835126)
4. Sadreyev, R.I.; Grishin, N.V. Exploring dynamics of protein structure determination and homology-based prediction to estimate the number of superfamilies and folds. BMC Struct. Biol. 2006, 6, 6.
5. Lipkin, M.J.; Stevens, A.P.; Livingstone, D.J.; Harris C.J. How large does a compound screening collection need to be? Comb. Chem. High Throughput Screen. 2008, 11, 482-493
6. Bredel, M; Jacoby, E. Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat. Rev. Genet. 2004, 5, 262-275 (Pubitemid 38435622)
7. Jacoby, E.; Schuffenhauer, A.; Popov, M.; Azzaoui, K.; Havill, B.; Schopfer, U.; Engeloch, C.; Stanek, J.; Acklin, P.; Rigollier, P.; Stoll, F.; Koch, G.; Meier, P.; Orain, D.; Giger, R.; Hinrichs, J.; Malagu, K.; Zimmermann, J.; Roth, H.J. Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection. Curr. Top. Med. Chem. 2005, 5, 397-411.
8. Jacoby, E.; Schuffenhauer, A.; Azzaoui, K.; Popov, M.; Dressler, S.; Glick, M.; Jenkins, J.; Davies, J.; Roggo, S. Small molecules for chemogenomics-based drug discovery. In Chemogenomics - Knowledge-based Approaches to Drug Discovery; Jacoby, E., Ed. Imperial College Press, London, 2006; pp.1-38.
9. Gray, N.S.; Wodicka, L.; Thunnissen, A.M.; Norman, T.C.; Kwon, S.; Espinoza, F.H.; Morgan, D.O.; Barnes, G.; LeClerc, S.; Meijer, L.; Kim, S.H.; Lockhart, D.J.; Schultz, P.G. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 1998, 281, 533-538
10. Jacoby, E.; Fauchere, J.L.; Raimbaud, E.; Ollivier, S.; Michel, A.; Spedding, M. A three binding site hypothesis for the interaction of ligands with monoamine G protein-coupled receptors: implications for combinatorial ligand design. Quant. Struct.-Act. Relat. 1999, 18, 561-572 (Pubitemid 30018846)
11. Savchuk, N.P.; Tkachenko, S.E.; Balakin, K.V. Strategies for the design of pGPCR-targeted libraries. In Methods and Principles in Medicinal Chemistry (2006), 30 (Ligand Design for G Protein- Coupled Receptors); Rognan, D., Ed. Wiley-VCH, Weinheim, 2006; pp. 137-64.
12. Baringhaus, K.H.; Hessler, G. A chemical genomics approach for ion channel modulators. In Methods and Principles in Medicinal Chemistry (2004), 22 (Chemogenomics in Drug Discovery). Kubinyi, H.; Müller, G., Eds. Wiley-VCH, Weinheim, 2004; pp. 221-242
13. Harris, C.J.; Stevens, A.P. Chemogenomics: structuring the drug discovery process to gene families. Drug Discov. Today. 2006, 11, 880-888
14. Liao, J.J. Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. J. Med. Chem. 2007, 50, 409-424
15. Papp, A.; Szommer, T.; Barna, L.; Gyimesi, G.; Ferdinandy, P.; Spadoni, C.; Darvas, F.; Fujita, T.; Urge, L.; Dorman, G. Enhanced hit-to-lead process using bioanalogous lead evolution and chemogenomics: application in designing selective matrix metalloprotease inhibitors. Expert Opin. Drug Discov. 2007, 2, 707-723 (Pubitemid 47064964)
16. Sedrani, R.; Hommel, U.; Eder, J. Protease-Directed Drug Discovery. In Gene Family Targeted Molecular Design; Lackey, K., Ed; Wiley&Sons: New-York, 2008; pp.159-198
17. Moore, J.T.; Collins, J.L.; Pearce, K.H. The nuclear receptor superfamily and drug discovery. In Chemical Biology - From Small Molecules to Systems Biology and Drug Design. Schreiber, S.L.; Kapoor, T.M.; Wess, G., Eds. Wiley-VCH, Weinheim, 2007; pp. 891-932.
18. Pierce, A.C.; Rao, G.; Bemis, G.W. BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease. J. Med. Chem. 2004, 47, 2768-2775
19. Lewis, J.A.; Lebois, E.P.; Lindsley, C.W. Allosteric modulation of kinases and GPCRs: design principles and structural diversity. Curr. Opin. Chem. Biol. 2008, 12, 269-280
20. Evans, B.E.; Rittle, K.E.; Bock, M.G.; DiPardo, R.M.; Freidinger, R.M.; Whitter, W.L.; Lundell, G.F.; Veber, D.F.; Anderson, P.S.; Chang, R.S. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J. Med. Chem. 1988, 31, 2235-2246
21. Müller, G. Target family-directed masterkeys in chemogenomics. In Methods and Principles in Medicinal Chemistry (2004), 22 (Chemogenomics in Drug Discovery). Kubinyi, H.; Müller, G., Eds. Wiley-VCH, Weinheim, 2004, pp. 7-41.
22. Willoughby, C.A.; Hutchins, S.M.; Rosauer, K.G.; Dhar, M.J.; Chapman, K.T.; Chicchi, G.G.; Sadowski, S.; Weinberg, D.H.; Patel, S.; Malkowitz, L.; Di Salvo, J.; Pacholok, S.G.; Cheng, K. Combinatorial synthesis of 3-(amidoalkyl) and 3-(aminoalkyl)-2- arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptors. Bioorg. Med. Chem. Lett. 2002, 12, 93-96 (Pubitemid 34008577)
23. Bondensgaard, K.; Ankersen, M.; Thøgersen, H.; Hansen, B.S.; Wulff, B.S.; Bywater, R.P. Recognition of privileged structures by G-protein coupled receptors. J. Med. Chem. 2004, 47, 888-899 (Pubitemid 38176791)
24. Bywater, R.P. Privileged structures in GPCRs. Ernst Schering Found. Symp. Proc. 2006, 2, 75-91.
25. Bemis, G.W.; Murcko, M.A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 1996, 39, 2887-2893
26. Grabowski, K.; Schneider, G. Properties and architecture of drugs and natural products revisited. Curr. Chem. Biol. 2007, 1, 115-127
27. Kombarov, R.; Altieri, A.; Genis, D.; Kirpichenok, M.; Kochubey, V.; Rakitina, N.; Titarenko, Z. BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery. Mol. Divers. 2009, in Press, PMID: 19468851.
28. Schnur, D.M.; Hermsmeier, M.A.; Tebben, A.J. Are target-family-privileged substructures truly privileged? J. Med. Chem. 2006, 49, 2000-2009
29. Eguchi, M.; McMillan, M.; Nguyen, C.; Teo, J.L.; Chi, E.Y.; Henderson, W.R. Jr.; Kahn, M. Chemogenomics with peptide secondary structure mimetics. Comb. Chem. High Throughput. Screen. 2003, 6, 611-621 (Pubitemid 38017490)
30. Marshall, G.R.; Kuster, D.J.; Che, Y. Chemogenomics with protein secondary structure mimetics. In Chemogenomics: Methods and Applications; Jacoby, E., Ed. Humana Press, New-York, 2009, in Press.
31. Garland, S.L.; Dean, P.M. Design criteria for molecular mimics of fragments of the beta-turn. 1. C alpha atom analysis. J. Comput. Aided Mol. Des. 1999, 13, 469-483 (Pubitemid 29395562)
32. Garland, S.L.; Dean, P.M. Design criteria for molecular mimics of fragments of the beta-turn. 2. C alpha-C beta bond vector analysis. J. Comput. Aided Mol. Des. 1999, 13, 485-498 (Pubitemid 29395563)
33. Webb, T.R.; Jiang, L.; Sviridov, S.; Venegas, R.E.; Vlaskina, A.V.; McGrath, D.; Tucker, J.; Wang, J.; Deschenes, A.; Li, R. Application of a novel design paradigm to generate general nonpeptide combinatorial templates mimicking beta-turns: synthesis of ligands for melanocortin receptors. J. Comb. Chem. 2007, 9, 704-710
34. Fletcher, S.; Hamilton, A.D. Targeting protein-protein interactions by rational design: mimicry of protein surfaces. J. R. Soc. Interface. 2006, 3, 215-233
35. Che, Y.; Brooks, B.R.; Marshall, G.R. Protein recognition motifs: design of peptidomimetics of helix surfaces. Biopolymers 2007, 86, 288-297
36. Rodriguez, J.M.; Hamilton, A.D. Benzoylurea oligomers: synthetic foldamers that mimic extended alpha helices. Angew. Chem. Int. Ed. Engl. 2007, 46, 8614-8617
37. Volonterio, A.; Moisan, L.; Rebek, J. Jr. Synthesis of pyridazine-based scaffolds as alpha-helix mimetics. Org. Lett. 2007, 9, 3733-3736
38. Biros, S.M.; Moisan, L.; Mann, E.; Carella, A.; Zhai, D.; Reed, J.C.; Rebek, J. Jr. Heterocyclic alpha-helix mimetics for targeting protein-protein interactions. Bioorg. Med. Chem. Lett. 2007 , 17, 4641-4645 (Pubitemid 47064505)
39. Rodriguez, J.M.; Nevola, L.; Ross, N.T.; Lee, G.I.; Hamilton, A.D. Synthetic inhibitors of extended helix-protein interactions based on a biphenyl 4,4′-dicarboxamide scaffold. Chembiochem 2009, 23, 829-833
40. Parks, D.J.; Player, M.R. Alpha-helix mimetics: progress toward effective modulation of protein-protein complexes. Frontiers in Drug Design and Discovery. 2007, 3, 5-44.
41. [41 ] Singh, R. ; Mozzarelli, A. Cofactor chemogenomics. In Chemogenomics: Methods and Applications; Jacoby, E., Ed. Humana Press, New-York, 2009, in Press.
42. Ji, H.F.; Kong, D.X.; Shen, L.; Chen, L.L.; Ma, B.G.; Zhang, H.Y. Distribution patterns of small-molecule ligands in the protein universe and implications for origin of life and drug discovery. Genome Biol. 2007, 8, R176.
43. Denessiouk, K.A.; Johnson, M.S. When fold is not important: a common structural framework for adenine and AMP binding in 12 unrelated protein families. Proteins 2000, 38, 310-326
44. Denessiouk, K.A.; Rantanen, V.V.; Johnson, M.S. Adenine recognition: a motif present in ATP-, CoA-, NAD-, NADP-, and FAD-dependent proteins. Proteins 2001, 44, 282-291
45. Knapp, M.; Bellamacina, C.; Murray, J.M.; Bussiere, D.E. Targeting cancer: the challenges and successes of structure-based drug design against the human purinome. Curr. Top. Med. Chem. 2006, 6, 1129-1159
46. Amadasi, A.; Bertoldi, M.; Contestabile, R.; Bettati, S.; Cellini, B.; di Salvo, M.L.; Borri-Voltattorni, C.; Bossa, F.; Mozzarelli, A. Pyridoxal 5′-phosphate enzymes as targets for therapeutic agents. Curr. Med. Chem. 2007, 14, 1291-1324 (Pubitemid 46746362)
47. Sem, D.S.; Bertolaet, B.; Baker, B.; Chang, E.; Costache, A.D.; Coutts, S.; Dong, Q.; Hansen, M.; Hong, V.; Huang, X.; Jack, R.M.; Kho, R.; Lang, H.; Ma, C.T.; Meininger, D.; Pellecchia, M.; Pierre, F.; Villar, H.; Yu, L. Systems-based design of bi-ligand inhibitors of oxidoreductases: filling the chemical proteomic toolbox. Chem. Biol. 2004, 11, 185-194 (Pubitemid 38300289)
48. Ge, X.; Wakim, B.; Sem, D.S. Chemical proteomics-based drug design: target and antitarget fishing with a catechol-rhodanine privileged scaffold for NAD(P)(H) binding proteins. J. Med. Chem. 2008, 51, 4571-4580
49. Burke, M.D.; Schreiber, S.L. A planning strategy for diversity-oriented synthesis. Angew. Chem. Int. Ed. Engl. 2004, 43, 46-58.
50. Thomas, G.L.; Spandl, R.J.; Glansdorp, F.G.; Welch, M.; Bender, A.; Cockfield, J.; Lindsay, J.A.; Bryant, C.; Brown, D.F.; Loiseleur, O.; Rudyk, H.; Ladlow, M.; Spring, D.R. Anti-MRSA agent discovery using diversity-oriented synthesis. Angew. Chem. Int. Ed. Engl. 2008, 47, 2808-2812
51. Kaiser, M.; Wetzel, S.; Kumar, K.; Waldmann, H. Biology-inspired synthesis of compound libraries. Cell Mol. Life. Sci. 2008, 65, 1186-1201
52. Koch, M.A.; Schuffenhauer, A.; Scheck, M.; Wetzel, S.; Casaulta, M.; Odermatt, A.; Ertl, P.; Waldmann, H. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17272-17277
53. Koch, M.A.; Wittenberg, L.O.; Basu, S.; Jeyaraj, D.A.; Gourzoulidou, E.; Reinecke, K.; Odermatt, A.; Waldmann, H. Compound library development guided by protein structure similarity clustering and natural product structure. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 16721-16726 (Pubitemid 39601305)
54. Gillet, V.J. New directions in library design and analysis. Curr. Opin. Chem. Biol. 2008, 12, 372-378